Minigene splicing assay is undoubtedly useful and popular method to dissect splicing regulation, its aberrations, etc. When used for detecting the effect of mutations on splicing, most of its reported results are generally consistent with the results from patient's blood. However, sometimes the method just can not be used. As has been reported in Lastella et al., 2006, some of the cloned exons might be totally excluded from the final transcript (even in the wild type form), preventing any investigation of mutations effect. Possible explanation is that the cloned exon needs a larger genomic context for its proper recognition, as in Baralle et al., 2006. But, we have encountered a case that can not be explained such easily.

In our case, we have cloned exon 10 of the was gene into the pET01 vector (MoBiTec). In 2011, we saw partial exon inclusion in HeLa cells (circa 80 % exon inclusion, 20 % exon skipping by estimation). However, in 2013, we repeatedly detected only exon skipping – both in HeLa and U-937 cell lines. There was no change of the cell lines between these experiments, only ordinary cultivation. As we really sought to work with this exon, we have cloned it into the pET01 in a larger genomic context: exons 8–11 with parts of surrounding introns. Still, we could detect only exon 10 skipping in HeLa cells, as well as in U-937, HepG2 and EBV-infected lines. Later, we have purchased a new stock of the HeLa cell line. No surprise came: once again, we have detected only exon 10 skipping (tested only in the larger context). Of note: the first HeLa cell line was originally ordered from ATCC and the second one from ECACC, both credible sources.

Do you have any idea, what might have happened? Or do you have any similar experience, some minigene-related troubles? Maybe we could make a leap forward to find a solution together. I really look forward to discussing these issues.

http://www.ncbi.nlm.nih.gov/pubmed/16995940

http://www.ncbi.nlm.nih.gov/pubmed/16870183

More Lucie Grodecká's questions See All
Similar questions and discussions